Skip to content

Monitoring of patients with diabetes in a general hospital in Japan: a retrospective observational study

Monitoring of patients with diabetes in a general hospital in Japan: a retrospective observational study - Monitoring of patients with diabetes in a general hospital in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028129
Enrollment
300
Registered
2017-07-07
Start date
2017-07-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Sponsors

General Inuyama Chuo Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 300 patients with diabetes who are visiting Department of Diabetes in General Inuyama Chuo Hospital on June 2016

Exclusion criteria

Exclusion criteria: Patients who were known not to visit our hospital constantly

Design outcomes

Primary

MeasureTime frame
Dropout rate of outpatients on observation completed

Secondary

MeasureTime frame
Continuous rate of outpatients on observation completed Values of HbA1c and BMI in patients with observation completed on start and finish of observation Percent complete of HbA1c less than 7% in patients with observation completed on start and finish of observation Mortality during observation period (infection, total) Incidence of 3 point mace during observation period Incidence of admission during observation period (infection, total) Relationships of HbA1c with mortality and incidence of 3 point mace and admission during observation period (mean, standard deviation and coefficient of variation from start to finish of observation (on events occurrence), on start of observation, on finish of observation (on events occurrence)) Existences of antidiabetic agents usage in patients with observation completed on start and finish of observation Relationships of antidiabetic agents usage on start and finish of observation with mortality and incidence of 3 point mace and admission during observation period

Countries

Japan

Contacts

Public ContactSoichi Takeishi

General Inuyama Chuo Hospital Department of Diabetes

souichi19811225@yahoo.co.jp0568628111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026